U.S. Machinery Stock News

Surgery Partners (SGRY) updated its 2026 outlook, guiding revenue to a range of $3.08b to $3.18b. The revision reflects the removal of Idaho Falls Facilities’ contribution for the rest of the year. The updated 2026 outlook lands as Surgery Partners’ share price has been under pressure, with the stock down 7.86% over the past week and 13.17% year to date on a share price return basis, while the 1-year total shareholder return has declined 38.71%. This points to fading momentum as investors...

Advance Auto Parts recently opened a new store and market hub in Woodbridge, New Jersey, as part of a broader supply chain overhaul that consolidates its distribution footprint from 38 centers to 12 by 2026. This tighter network is designed to cut logistics costs and sharpen in-stock availability, which affects the core economics of how Advance Auto Parts serves professional and retail customers. We will now explore how this consolidation of 38 distribution centers into 12 could reshape...

Interparfums (IPAR) extended its exclusive global license for Roberto Cavalli and Just Cavalli fragrances by 20 years to December 31, 2046, providing investors with a clearer view of long-term brand access. Recent price action suggests steady interest in Interparfums, with the 1 day share price return of 1.60% and 90 day share price return of 13.54% sitting alongside a 1 year total shareholder return of 14.71% and 5 year total shareholder return of 78.61%. This indicates momentum that has...

AerCap Holdings announced that its board authorized a share repurchase program on 16 September 2026, allowing the company to buy back up to US$1.0b of its stock through 30 June 2027. The program will be funded by cash on hand and cash generated from operations. The new buyback plan indicates that AerCap Holdings is comfortable using ongoing operating cash flows for capital returns. This is relevant for investors who are weighing future balance sheet flexibility against potential benefits...

Carter's new collection and what it might mean for the stock Carter's (CRI) is rolling out its Not-So-Scary Monsters sleepwear and playwear line, pairing character driven bedtime routines with an in app Monster Room Scanner, giving investors a fresh product story to watch. Recent trading has been rough for Carter's, with the share price at about $29.64 after a 30 day share price return that declined 20.3% and a 90 day share price return that fell 30.3%. The 1 year total shareholder return is...

Green Brick Partners and HFI Capital Management recently marked a key milestone at the Rainwater Crossing master-planned community in Celina, Texas with the opening of Whispering Grove, a two-acre entrance park that anchors a planned 1,800-home development featuring extensive parks, trails, and future amenity centers. The combination of visible progress at Rainwater Crossing and CEO Jim Brickman’s comments on capital strength and potential builder acquisitions provides investors with more...

Incyte reported that MINJUVI, a humanized anti CD19 antibody used with rituximab and lenalidomide for relapsed or refractory follicular lymphoma, is now funded in Ontario through the FAST Program. This gives eligible patients earlier access while reimbursement discussions continue. This Ontario FAST listing for MINJUVI highlights how payer decisions can shape real world demand patterns and operating visibility for Incyte’s broader oncology portfolio. We will now examine how Incyte's...

Greif, Inc. has exited the coated recycled paperboard market after shutting its Sweetwater mill in Austell, Georgia. This removes roughly 120,000 tons of annual capacity and affects around 90 employees, who are receiving severance and career support. The Sweetwater closure highlights Greif’s push to concentrate capital on operations with stronger competitive positions and better integration across its North American paperboard network. We will now examine how Greif’s decision to close the...

Maze Therapeutics (MAZE) has drawn investor attention after a weak run for the shares, with the price down 24% over the past month and 12% over the past 3 months. That short-term weakness sits against a tougher backdrop for Maze Therapeutics, with the year-to-date share price return down 43.37% even though the 1-year total shareholder return is only 1.83% lower. Momentum has clearly faded, and recent moves suggest investors are reassessing both growth potential and clinical or funding risks...

Why Teladoc Health’s latest earnings matter for investors Teladoc Health (TDOC) set the tone for the stock this week after reporting quarterly results that showed a 4% revenue decline, missed forecasts on profitability, and softer guidance for the coming quarter. The update pointed to a 9.2% average drop in customer spending in recent years even as user counts grew. Management signaled expectations for another period of lower revenue and negative earnings per share. Recent trading suggests...

Bond markets have stolen the spotlight in 2026, with surging government yields, pricier mortgages and renewed inflation worries shaking assumptions about what different stocks are really worth. That stress creates an opportunity for investors who understand how trading platforms and custody firms can be affected when cash becomes more valuable and bond markets swing harder. This article walks through three stocks exposed to this story and explains how the recent move in yields could matter...

Ituran Location and Control reported record Q2 2026 revenue of US$104.8 million, with recurring subscription income and total subscribers both higher. The Israeli Ministry of Transport also awarded the business a multi year SaaS traffic monitoring contract worth over NIS 21 million. The new agreement for a nationwide Big Data traffic platform signals that Ituran Location and Control’s proprietary analytics are being adopted for core public infrastructure decisions, extending the telematics...

Lennar reported weaker third quarter 2026 results, with revenue of US$8.0b and net income of US$283.88 million, and cut full year home delivery guidance amid higher mortgage rates and softer housing demand. The builder is relying on price cuts and heavier incentives to keep orders flowing, which pressures margins while it continues investing in new communities such as Cherokee Bend, The Farm, Amberwood and expanded amenities at Tuckers Cove. We will now explore how Lennar's softer quarter,...

Fortrea Holdings reinstated Jason Knoblauch as Chief Financial Officer and principal financial officer on September 9, 2026, after reaching a settlement and mutual release with his former employer that resolved prior legal restrictions on his role. The resolution of the dispute and return of a permanent CFO reduces uncertainty around Fortrea Holdings' finance function at a time when execution on cost programs, third party reliance, and concentrated customer exposure remain key operational...

Baker Hughes reported a large order to supply 13 Frame 5/2E gas turbine driven gas compression systems and modular liquefaction blocks, including cold boxes, for Venture Global’s Cloud Connector Pipeline and Plaquemines LNG expansion in Louisiana, supporting more than 100 MTPA of existing and planned LNG capacity. The deal deepens Baker Hughes’ role across the LNG value chain by pairing pipeline feed gas compression with electric motor driven SMR liquefaction modules, air coolers and...

Broadcom has delivered a very large 5 year share price gain, yet the recent pullback and fresh headlines around AI chips and regulation leave a simple question for you as a holder or would be buyer. Is the current valuation properly backed by the cash the business can generate over time, or has sentiment moved faster than its underlying cash flows. Broadcom has returned about 7x over the past 5 years, which puts a lot of future cash generation assumptions under the spotlight for anyone...

Texas Instruments announced a 7% increase to its quarterly cash dividend, from $1.42 to $1.52 per share, or $6.08 annualized, payable on November 10, 2026 to holders of record on October 30, 2026, subject to formal board approval. The higher payout, which extends Texas Instruments' streak to 23 consecutive years of dividend raises, reflects management's stated aim to return all free cash flow to shareholders over time while continuing its capacity expansion program. This article will examine...

MARA Holdings (MARA) has been in focus after a 6.9% jump to US$12.45 on heavy volume, even as JP Morgan shifted to an Underweight rating and took a more cautious stance. Set against that reaction, MARA Holdings now trades at US$13.24, with a 1-day share price return of 13.75% and a 7-day share price return of 10.52%. However, the 1-year total shareholder return is down 27.61%, while the 3-year total shareholder return is up 52.71%. This mix points to short term momentum building on a more...

Sterling Infrastructure (STRL) moved into focus after recent research pointed to projections for both EPS and revenue ahead of its upcoming earnings release, sharpening attention on how expectations match reality. Sterling Infrastructure’s latest 2.56% one-day share price gain to US$518.68 comes after several upbeat earnings previews. However, the 90-day share price return is down 39.82%, so recent momentum has cooled, even as the 62.51% year-to-date share price return and very large...

Avantor recently expanded availability of its RIM single-use bioprocessing portfolio across the Asia Pacific region, including local manufacturing capacity in China, to better support regional biopharma producers. This move ties directly into Avantor's Revival strategy, connecting commercial execution and manufacturing productivity with on-the-ground support for APAC biologics demand and supply reliability. We will now look at how Avantor's broader investment narrative is affected by the...

Target Hospitality (TH) has moved back into focus after completing a US$259 million follow on equity offering at US$18.50 per share, increasing its common stock float. That equity sale comes at a time when Target Hospitality’s momentum has been picking up, with a 30 day share price return of 24.35% and a year to date share price gain of 161.60%, contributing to a 1 year total shareholder return of 144.69% and a very large 5 year total shareholder return that suggests investors may already be...

Nutex Health recently reported a sharply stronger earnings outlook, with the Zacks Consensus Estimate for current year earnings improving 21.4% over the last 60 days and expected earnings growth for the year now projected at more than 100%. This rapid shift in Nutex Health’s profit expectations highlights how the company’s physician-led, tech-enabled micro hospitals and population health operations are beginning to translate operating momentum into a materially different earnings profile. We...

Karman Holdings (KRMN) has drawn fresh attention after recent trading left the share price at US$35.75. Short term moves look modest; however, the past month and past 3 months show sharper declines. Over the past year, momentum in Karman Holdings has faded, with the share price return down 53.48% year to date and the 1-year total shareholder return down 45.93%. The sharp 30-day share price decline of 38.57% points to a recent reset in growth expectations or perceived risk. Pressure test...

Shopify shares have pulled back over the past year after a strong multi year run, which puts fresh attention on whether the current US$128.50 price still lines up with the cash the business is expected to generate. For investors watching the swings, the core issue is how that market value stacks up against the intrinsic value suggested by its cash flows. Over the past 3 years the stock has delivered a 142.1% gain. As a result, a lot of optimism about Shopify's future cash generation is...